In Conversation With... Mark Lythgoe

from Listen to The Lancet Oncology · host The Lancet

Dr Mark Lythgoe (Imperial College London, London, UK), discusses his new Review, "From The European Medicines Agency to Project Orbis: New activities and challenges to facilitate UK Oncology Drug Approval following Brexit".

Episode metadata supplied by the publisher feed · Published Mar 28, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

In Conversation With... Mark Lythgoe

0:00 14:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Oncology?

This episode is 14 minutes long.

When was this Listen to The Lancet Oncology episode published?

This episode was published on March 28, 2023.

Can I download this Listen to The Lancet Oncology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!